Amid swirling speculation, Bausch + Lomb ($BLCO), a global leader in the contact lens supply industry, is reportedly ...

Bausch + Lomb is also in the process of seeking regulatory approvals for the lens in additional markets ... The enVista Envy toric hydrophobic acrylic IOL is indicated for primary implantation ...

Dr. Alexander Harris, president of Slocum Dickson Medical Group and director of The Eye Care Center at SDMG, was chosen to be ...

Eye health firm Bausch + Lomb has received marketing approval for its full range of enVista Envy vision intraocular lenses (IOL) from the US Food and Drug Administration (FDA). Following the ...

Objectives: To characterize toric contact lens prescribing worldwide. Methods: Up to 1,000 survey forms were sent to contact lens fitters in up to 39 countries between January and March every year ...

Good morning and welcome to Bausch + Lomb’s Third Quarter 2024 Earnings Call. [Operator Instructions] Please note this event ...

Designed to help maximize efficiencies for eye care practices while enhancing the patient experience, Opal provides a streamlined ordering process for Bausch + Lomb contact lenses, with select ...

lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Bausch + Lomb Corporation (BLCO – Research Report) yesterday and set a ...

Opal provides a streamlined ordering process for Bausch + Lomb contact lenses. Why is that important ... the multifocal and the toric. And we're looking at over the next year or 2, launching ...